Marker Therapeutics, Inc.

Daily Archives: Wednesday, July 18, 2018

New Details Emerge on TapImmune Merger

TapImmune Inc., Jacksonville’s publicly traded developer of cancer-fighting immunotherapies, announced in May that it was merging with Minnesota-based Marker Therapeutics Inc., another developer of immunotherapies.

Read More